The following table provides a comparative overview for researchers considering these two compounds for their in-vitro studies
Mohammadi F, Nejatollahi M, Sheikhnia F, Ebrahimi Y, Mohammadi M, Rashidi V, Alizadeh-Fanalou S, Azizzadeh B, Majidinia M (2025) MiRNAs: main players of cancer drug resistance target ABC transporters
STEP-1: Semaglutide 2,4 mg, the standard since 2021 The STEP-1 trial (Wilding et al., NEJM 2021, PMID 33567185) randomized 1,961 overweight or obese adults (BMI 30 or BMI 27 with comorbidities) without diabetes to semaglutide 2,4 mg/week or placebo, with lifestyle interventions administered concurrently in both arms
At SpaRx, we offer advanced, medically supervised weight management programs designed to support appetite regulation, metabolic efficiency, and sustainable fat reduction
Gastrointestinal Issues The most common side effect of magnesium is diarrhea